171 related articles for article (PubMed ID: 16412048)
1. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice.
Kitagaki K; Businga TR; Kline JN
Clin Exp Immunol; 2006 Feb; 143(2):249-59. PubMed ID: 16412048
[TBL] [Abstract][Full Text] [Related]
2. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma.
Jain VV; Kitagaki K; Businga T; Hussain I; George C; O'shaughnessy P; Kline JN
J Allergy Clin Immunol; 2002 Dec; 110(6):867-72. PubMed ID: 12464952
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL
Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938
[TBL] [Abstract][Full Text] [Related]
4. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
5. CpG-ODNs and Budesonide Act Synergistically to Improve Allergic Responses in Combined Allergic Rhinitis and Asthma Syndrome Induced by Chronic Exposure to Ovalbumin by Modulating the TSLP-DC-OX40L Axis.
Li HT; Chen ZG; Lin YS; Liu H; Ye J; Zou XL; Wang YH; Yang HL; Zhang TT
Inflammation; 2018 Aug; 41(4):1304-1320. PubMed ID: 29654433
[TBL] [Abstract][Full Text] [Related]
6. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides.
Kline JN; Kitagaki K; Businga TR; Jain VV
Am J Physiol Lung Cell Mol Physiol; 2002 Jul; 283(1):L170-9. PubMed ID: 12060574
[TBL] [Abstract][Full Text] [Related]
7. CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma.
Kline JN; Krieg AM; Waldschmidt TJ; Ballas ZK; Jain V; Businga TR
J Allergy Clin Immunol; 1999 Dec; 104(6):1258-64. PubMed ID: 10589010
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure.
Jain VV; Businga TR; Kitagaki K; George CL; O'Shaughnessy PT; Kline JN
Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1137-46. PubMed ID: 12857672
[TBL] [Abstract][Full Text] [Related]
9. Treatment of allergic rhinitis with CpG oligodeoxynucleotides alleviates the lower airway outcomes of combined allergic rhinitis and asthma syndrome via a mechanism that possibly involves in TSLP.
Li HT; Chen ZG; Liu H; Ye J; Zou XL; Wang YH; Yang HL; Meng P; Zhang TT
Exp Lung Res; 2016 Aug; 42(6):322-33. PubMed ID: 27541375
[TBL] [Abstract][Full Text] [Related]
10. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
11. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses.
Kitagaki K; Jain VV; Businga TR; Hussain I; Kline JN
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1260-9. PubMed ID: 12414759
[TBL] [Abstract][Full Text] [Related]
13. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
14. A single, low dose oral antigen exposure in newborn piglets primes mucosal immunity if administered with CpG oligodeoxynucleotides and polyphosphazene adjuvants.
Pasternak JA; Ng SH; Wilson HL
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):211-21. PubMed ID: 25194591
[TBL] [Abstract][Full Text] [Related]
15. The enhanced effect of a hexameric deoxyriboguanosine run conjugation to CpG oligodeoxynucleotides on protection against allergic asthma.
Park Y; Chang YS; Lee SW; Cho SY; Kim YK; Min KU; Kim YY; Cho SH; Sung YC
J Allergy Clin Immunol; 2001 Oct; 108(4):570-6. PubMed ID: 11590383
[TBL] [Abstract][Full Text] [Related]
16. Microneedle-Mediated Allergen-Specific Immunotherapy for the Treatment of Airway Allergy in Mice.
Shakya AK; Lee CH; Gill HS
Mol Pharm; 2020 Aug; 17(8):3033-3042. PubMed ID: 32643940
[TBL] [Abstract][Full Text] [Related]
17. Splenic dendritic cells induced by oral antigen administration are important for the transfer of oral tolerance in an experimental model of asthma.
Nagatani K; Dohi M; To Y; Tanaka R; Okunishi K; Nakagome K; Sagawa K; Tanno Y; Komagata Y; Yamamoto K
J Immunol; 2006 Feb; 176(3):1481-9. PubMed ID: 16424176
[TBL] [Abstract][Full Text] [Related]
18. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K
J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis.
San Román B; Irache JM; Gómez S; Gamazo C; Espuelas S
Int Arch Allergy Immunol; 2009; 149(2):111-8. PubMed ID: 19127067
[TBL] [Abstract][Full Text] [Related]
20. IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation.
Kawakami H; Koya T; Kagamu H; Kimura Y; Sakamoto H; Yamabayashi C; Furukawa T; Sakagami T; Miyabayashi T; Hasegawa T; Suzuki E; Narita I
Clin Exp Allergy; 2012 Jun; 42(6):946-57. PubMed ID: 22909166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
